Biotechnology momentum in Canada needs infusion of talent and anchor firms, say industry reps

Canada has several prominent life science firms, but none can be considered an anchor company, according to a report by the adMare Institute released in late 2023.

Innovation Minister François-Philippe Champagne said the government is committed to supporting innovation in the life sciences sector to ensure Canadians have access to 'cutting-edge medical technologies to keep them safe,' in a July 9 press release.The Hill Times photograph by Andrew Meade

News

BY JESSE CNOCKAERT

September 18, 2024

Capitalizing on momentum in Canada’s biotechnology sector gained during the COVID-19 pandemic will require a strategy to draw and retain more talent, as well as “anchor companies” to help ensure long-term successes in the industry, according to the president and CEO of...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy